by evommune | Dec 4, 2023
Kyle Carver serves as Chief Financial Officer of Evommune. Prior to joining Evommune, Kyle was Chief Accounting Officer at Kadmon, a Sanofi Company, where he oversaw all aspects of financial and accounting operations, including Kadmon’s transition to a public company...
by evommune | Dec 4, 2023
Gregory S. Moss serves as the Chief Business and Legal Officer, Corporate Secretary and Chief Compliance Officer of Evommune. Prior to Evommune, Greg served as Executive Vice President, General Counsel and Corporate Secretary, Chief Compliance Officer at Kadmon, where...
by evommune | Dec 4, 2023
Dr. Jeegar Patel is the Chief Scientific Officer at Evommune. He brings deep expertise in translational science and nonclinical development, with a track record of advancing innovative therapies from early research through regulatory approval. Prior to joining...
by evommune | Dec 4, 2023
Janice Drew is Chief of Development Operations at Evommune. Janice has over 30 years of experience in clinical development covering early-stage research, Phase 1 through Phase 3 clinical trials, and development activities through the commercialization and...
by evommune | Dec 4, 2023
Dr. Lou Sehl is Senior Vice President, Technical Operations of Evommune. Lou has more than 30 years of experience in the biotechnology, pharmaceutical, and medical device industries, with a consistent track record of successfully moving projects through all phases of...
